%PDF-1.4
%
36 0 obj
<>
endobj
33 0 obj
<>
endobj
94 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-07-21T15:05:51Z
2024-03-28T16:47:09-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T16:47:09-07:00
application/pdf
Heather
2003-160.aug.suppl.67
uuid:fd872142-1dd1-11b2-0a00-b809276d7200
uuid:fd872144-1dd1-11b2-0a00-b80000000000
endstream
endobj
22 0 obj
<>
endobj
23 0 obj
<>
endobj
37 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 12 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 14 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 16 0 R/Type/Page>>
endobj
106 0 obj
[111 0 R]
endobj
107 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.03619 Tw 10 0 0 10 54 713.1616 Tm
(medical schools is to be increased by 2, with an increase in)Tj
0.05051 Tw 0 -1.21 TD
[(student numbers in some existing faculties. However)40 (, there)]TJ
0.00079 Tw T*
(has also been a fall in the number of applicants to medicine.)Tj
0.3038 Tw T*
[(Following qualification, general practice, particularly)65 (, is)]TJ
0.1156 Tw T*
(facing problems with recruitment and a small, but signifi-)Tj
-0.0359 Tw T*
(cant, minority of doctors are turning to careers outside medi-)Tj
0.15939 Tw T*
(cine. It is clear that the delivery of medical services will)Tj
0.2514 Tw T*
(need to change to accommodate a higher percentage of)Tj
0.0563 Tw T*
[(women graduates, which now is well in excess of 50%. )55 (As)]TJ
0.02859 Tw T*
(such, there is likely to be a drive towards more job sharing,)Tj
0.00909 Tw T*
(which many male specialists might find similarly attractive.)Tj
0.0199 Tc 0.4752 Tw 1.2 -1.2 Td
(Access to rheumatology services is not uniform)Tj
-0.00011 Tc 0.01089 Tw -1.2 -1.2 Td
[(throughout the UK. Moreover)40 (, the availability of treatments)]TJ
-0.0195 Tw 0 -1.2 TD
(for an individual can depend on geographical location rather)Tj
-0.03149 Tw T*
[(than clinical need. )18 (This has led to char)18 (ges of so-called \322post-)]TJ
0.02499 Tw T*
(code prescribing.\323)Tj
-0.02319 Tw 1.2 -1.2 Td
(Musculoskeletal disorders have a low profile with central)Tj
0.28819 Tw -1.2 -1.2 Td
[(government; they lack the emotive appeal of oncology)65 (,)]TJ
0.0295 Tw T*
(coronary artery disease, and disorders of children. In recent)Tj
0.2025 Tw T*
(years a number of initiatives known as National Service)Tj
0.3259 Tw T*
(Frameworks \(NSF\) have been introduced for particular)Tj
0.1756 Tw T*
[(disorders. )18 (These include the setting of explicit tar)18 (gets by)]TJ
0.1244 Tw T*
(government and have meant that, for example, cardiology)Tj
0.1402 Tw T*
(and oncology services have been able to obtain increased)Tj
0.1153 Tw T*
(resources in order to comply with the requirements of the)Tj
0.0484 Tw T*
[(NSF)80 (. Regrettably)65 (, none such exists, or is likely to exist, for)]TJ
0.02499 Tw T*
(musculoskeletal diseases.)Tj
/T1_1 1 Tf
0 Tw 0 -2.4 TD
[(Pr)18 (ospects)]TJ
/T1_0 1 Tf
0.10451 Tw 0 -1.2 TD
(There are certainly causes for cautious optimism. Funding)Tj
0.1263 Tw T*
(for health services, as outlined above, is increasing above)Tj
0.00909 Tw T*
[(the rate of inflation. )18 (The profession is introducing a number)]TJ
0.2272 Tw T*
(of defined clinical standards of care. Inroads are slowly)Tj
0.2791 Tw T*
(being made with regard to increasing awareness of the)Tj
0.02631 Tw T*
[(importance of musculoskeletal disorders and patients\325)-202 (or)18 (ga-)]TJ
0.1606 Tw T*
(nizations are proving to be enormously successful in this)Tj
0.106 Tw T*
[(regard. )18 (There has never been a wider choice of better and)]TJ
0.06329 Tw T*
[(safer treatments. )55 (Although some of these, most notably the)]TJ
-0.0218 Tw T*
(biologic agents, are hugely expensive \(approximately \2438000)Tj
0.0816 Tw T*
(per patient per annum in the UK\), this has to some degree)Tj
0.16521 Tw 26.4 46.9 Td
[(focused attention on rheumatology)65 (, since expensive treat-)]TJ
0.02859 Tw T*
(ments indicate, to the hitherto uninformed, that some of the)Tj
0.02499 Tw T*
(disorders we manage can be extremely serious.)Tj
/T1_1 1 Tf
0 -2.4 TD
[(Opportunities for)-257 (International Cooperation )]TJ
/T1_0 1 Tf
0.0199 Tc 0.50211 Tw 0 -1.2 TD
[(The UK is part of the European League )55 (Against)]TJ
0.01781 Tc 0.3571 Tw T*
(Rheumatism \(EULAR\) and the )Tj
/T1_2 1 Tf
0.35699 Tw 14.6312 0 Td
(Annals of Rheumatic)Tj
-0.00011 Tc 0 Tw -14.6312 -1.2 Td
(Diseases)Tj
/T1_0 1 Tf
-0.0208 Tw (, one of the two main UK rheumatology journals, is)Tj
0.2838 Tw T*
[(the of)18 (ficial EULAR publication. )18 (The British Society of)]TJ
0.12399 Tw T*
(Rheumatology \(BSR\) has enjoyed a number of successful)Tj
0.23711 Tw T*
(combined national meetings in conjunction with French,)Tj
-0.008 Tw T*
(Dutch, and Scandinavian rheumatology societies. Many UK)Tj
0.29739 Tw T*
[(rheumatologists now attend )55 (American meetings and the)]TJ
0.0029 Tc 0.37199 Tw T*
[(number of UK delegates to the )55 (American College of)]TJ
-0.00011 Tc -0.0062 Tw T*
(Rheumatology annual meeting is second only to the number)Tj
0.0329 Tw T*
(at the BSR annual scientific meeting. Increasing opportuni-)Tj
0.1093 Tw T*
(ties exist for research and for clinical fellowships in other)Tj
0.02499 Tw T*
[(European countries, the US, and )55 (Australia.)]TJ
0.0011 Tw 1.2 -1.2 Td
[(There is a strong need for the )18 (W)80 (orld Health Or)18 (ganization)]TJ
0.1956 Tw -1.2 -1.2 Td
(\(WHO\) to shout louder for the cause of musculoskeletal)Tj
0.0407 Tw T*
[(diseases. )18 (There have been notable successes and the )18 (WHO,)]TJ
0.30299 Tw T*
(with the United Nations, has given full support to the)Tj
0.0199 Tc 0.6553 Tw T*
[(International Bone and Joint Decade. )18 (The Japan)]TJ
-0.00011 Tc -0.0343 Tw T*
(Rheumatism Foundation, by virtue of this meeting, is setting)Tj
0.03979 Tw T*
(an example for other nations to follow and has provided an)Tj
0.3699 Tw T*
(invaluable opportunity to learn about the provision of)Tj
0.2419 Tw T*
(rheumatology services in many countries throughout the)Tj
0.23441 Tw T*
[(world. )18 (The sharing of such ideas can only benefit, ulti-)]TJ
0.2231 Tw T*
[(mately)65 (, those people who suf)18 (fer bone and joint diseases)]TJ
0.02499 Tw T*
(whom we are trained and so privileged to serve.)Tj
/T1_1 1 Tf
0 Tw 0 -2.4 TD
(REFERENCES)Tj
/T1_0 1 Tf
0.02499 Tw 8 0 0 8 325 331.1616 Tm
[(1.)-875 (Smith R. )18 (The failings of NICE. BMJ 2000;321:1363-4.)]TJ
0 -1.25 TD
[(2.)-875 (Dent HS, Sadler M. From guidance to practice: why NICE is not)]TJ
0 Tc 1.675 -1.25 Td
(enough. BMJ 2002;324:842-5.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(3.)-875 (T)35 (urner G, Symmons )55 (A, Bamji )55 (A, Palferman )18 (T)74 (. Consultant )]TJ
1.675 -1.25 Td
(rheumatology workforce in the UK: Changing patterns of provision)Tj
0 Tc T*
(1997-2001. Rheumatology 2002;41:680-4.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(4.)-875 (Kirwan JR. Rheumatology out-patient workload increases )]TJ
1.675 -1.25 Td
[(inexorably)65 (. Br J Rheumatol 1997;36:481-6.)]TJ
ET
0 0 0 0 k
408 770 150 -25 re
f*
0 0 0 1 K
54 54 m
558 54 l
S
BT
0 0 0 1 k
/T1_2 1 Tf
8 0 0 8 54.5 35.9844 Tm
(Palferman: UK perspective)Tj
0 Tc 0 Tw 61.9375 -0.0313 Td
(35)Tj
ET
0 0 0 0 k
/GS0 gs
109.22 59.09 396.48 -10.84 re
f*
0.5 w
109.22 59.09 396.48 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
ET
/GS2 gs
BT
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
16 0 obj
<>stream
8;Z\7>7SOn%-.='b]WX,6:5')/>-aqR\m6/*BU*."$"Y)8qD#t-YP@_=SlG>'-[I'
69(UZr+hVUm,qlY3/-[']nk\*"bG`N5#a[:YpGPEU0u);3Jl<>c$Qq)Ng^
dk?^RSr>o@6jsE`;O?CIf]%ja!Q>j__F2-ak/'j7m7SaE/\>+q(Y]ObIa;)u-j:5b
X0jRK.q8$*_:4's8l':2gY$#I^E!pGcXU=C2.:VseQ;?/"uoFdX94?Gq"5"M.e\[a
B0L(ZEDsk35qj?1VKIHmqb.Eh)L$pBWO$KB9-k[2#iBE7b2i%\*k1>$dV*'qbM/r+
4e]VscsG#1-5`Vh/*_\0'^C2lhAe^'nr43ncL"R]_+i.0SZ.$)XfL
^@W/BR%neCE,]c8n6<,pUiUWQM!Q#!cS)>1,n;=e!s!$GW&"~>
endstream
endobj
20 0 obj
[/Indexed/DeviceRGB 255 19 0 R]
endobj
19 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
49 0 obj
<>
endobj
47 0 obj
<>
endobj
43 0 obj
<>
endobj
63 0 obj
<>
endobj
100 0 obj
<>
endobj
40 0 obj
<>
endobj
56 0 obj
<>stream
HT{PSg7{$F^֪૭D-(. Q"@@!SѵjV+Vmڵ:햙cg7bg:sf|sw~;ǜ8ֆGlڼ J*(mR%Jwe;g_~$6Y'FNV#/ſpIv/=C3[,wq^]{琿:yF!ݝb=dy_)Y$O04JDd6+$I0kRSZ%(%LGt
1#U2 J$%(R.&L&Wi%̚P&!-i\HuJuR$MPH%_k_:}w6q1!1l -uV`Z
1#X88Yũ!\`BE\u:KzM$Wey^s]cVN;֥GR~tm& ({V#?8LNȝ;rTP鰬EW\m^U2KrM:Pp32@%`
#ܦٺ6\
:3;;pԸņW8
C?~Ϣ/z:ݨi3rˈIc]G OPn>@;Ӿ6 ˭tT[-ũ<b&p:ĸ>sվZ.>?<&0RL*!IA ,۶c#/G%!2Q?G85sMwÉͣM6ng萏X@ >8yH@vpQkɃLF#U[Z,.Ȼ$Cܝ1="]zOMPPK؞FXa3N?fL6l1e+
+oؾMZMD>j?
$l Q͗I1<6DQa4RS0
OIn8íhӨz_W!l HTT>܋悏FȂwLVMȏ8%(y
3LZ7 $R]7=cUTqy-6]e4df5֦
v`vr cYuғND֬q:ʍ7l=`T+G0v8rVGyͦ"+]?@